MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    The score changes of clinical symptom assessment scales for multiple system atrophy in 2-3 years

    M. Matsushima, I. Yabe, I. Takahashi, K. Sakushima, F. Nakano, M. Hirotani, T. Kano, K. Horiuchi, H. Houzen, H. Sasaki (Sapporo, Japan)

    Objective: To examine the extent of disease progression for multiple system atrophy (MSA) during relatively long duration. Background: The knowledge of MSA natural history is…
  • 2016 International Congress

    Frequency of GBA1 and LRRK2 G2019S mutations, and body mass index in Ashkenazi Jews

    N. Doan, D. Raymond, R.A. Ortega, J. Ratliff, I. Meijer, J. Squires, S. Buckingham, B. Johannes, A. Vaigast, I. Perera, W.C. Nichols, L. Ozelius, J. Miravite, L. Severt, V. Shanker, N. Lubarr, S. Bressman, R. Saunders-Pullman (New York, NY, USA)

    Objective: To evaluate the frequency and characteristics of parkinsonism and Parkinson's disease (PD) attributable to LRRK2 G2019S and Glucocerebrosidase1 (GBA1) mutations in Ashkenazi Jewish (AJ)…
  • 2016 International Congress

    The condition of cerebral hemodynamics in the secondary vascular parkinsonism

    D. Akramova, A. Umarov, G. Rakhimbaeva, M. Ataniyazov, D. Shosaidova (Tashkent, Uzbekistan)

    Objective: To study influence of narrowing lesion of the main brain arteries to progress of secondary vascular stenosis prognosticate stenosis degree and prevent risk factors…
  • 2016 International Congress

    Serum brain-derived neurotrophic factor as an indication of disease state in parkinsonism and RBD

    K. Csencsits-Smith, J. Suescun, A. Gonzalez, A. Actor, M. Schiess (Houston, TX, USA)

    Objective: Evaluation of peripheral concentrations of brain-derived neurotrophic Factor (BDNF) in patients with Parkinsonian disorders and correlation with clinical measurements of disease progression to elucidate…
  • 2016 International Congress

    Clinicopathological characteristics of co-existant Parkinson’s disease and corticobasal degeneration: A case study

    K. Andruska, C. Kilbane, E. Plowey, K. Poston (Stanford, CA, USA)

    Objective: Parkinsonism is characterized by bradykinesia, rigidity, rest tremor, and postural instability. The most common cause of parkinsonism is Parkinson's disease (PD) and, rarely, Parkinson-plus…
  • 2016 International Congress

    The effects of fluvoxamine maleate in a post-natal stress rat model of neurodegeneration

    E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)

    Objective: In this study, we investigated whether treatment of anxiety-like symptoms with Fluvoxamine maleate alleviates the neurotoxic effects of 6-OHDA in a Parkinsonian rat model.…
  • 2016 International Congress

    Premotor symptoms as prognostic indicators of Parkinson’s disease: A nationwide population-based and case-control study

    M.H. Chang (Taichung, Taiwan)

    Objective: To evaluate the association between the premotor symptoms and the prognosis of Parkinson's disease (PD) by utilizing Taiwan National Health Insurance Research Database. Background:…
  • 2016 International Congress

    Retinal nerve fiber layer thinning: A window into rapid eye movement sleep behavior disorders in Parkinson’s disease

    C.J. Mao, Z.J. Yang, J. Wei, J.R. Zhang, Y.P. Yang, C.F. Liu (Suzhou, People's Republic of China)

    Objective: To determine whether retinal structures are altered with the onset of rapid eye movement (REM) in Parkinson's disease (PD). Background: Rapid eye movement (REM)…
  • 2016 International Congress

    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease. PPMI cohort

    T. Simuni, D. Weintraub, C. Caspell-Garcia, M. Walker, C.S. Coffey, S. Lasch, C. Tanner, D. Jennings, K. Kieburtz, K. Marek, On behalf of the PPMI Investigators (Chicago, IL, USA)

    Objective: To examine baseline prevalence and longitudinal change in non-motor symptoms (NMS) in a cohort of de novo (at baseline) Parkinson's disease (PD) patients compared…
  • 2016 International Congress

    The impact of a movement disorders specialist on resident knowledge, as measured by the resident in-service training examination (RITE)

    A. Killoran (Morgantown, WV, USA)

    Objective: To determine a movement disorders specialist's impact on resident education, as assessed by the Resident In-Service Training Examination (RITE) scores. Background: Neurology resident knowledge…
  • « Previous Page
  • 1
  • …
  • 343
  • 344
  • 345
  • 346
  • 347
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley